Rock Creek Pharmaceuticals Receives Clinical Trial Application Approval

Rock Creek Pharmaceuticals Receives Clinical Trial Application Approval

All these studies demonstrated the anti-inflammatory effects of anatabine. In addition, the Company's compilation of human exposure, safety and tolerability data, derived primarily from human clinical studies and post-marketing data collection of the

(Visited 1 times, 1 visits today)
10
Like
Save

Comments

Comments are disabled for this post.